National Pension Service Purchases 105,229 Shares of Axon Enterprise, Inc $AXON

National Pension Service raised its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 119.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 193,535 shares of the biotechnology company’s stock after buying an additional 105,229 shares during the quarter. National Pension Service owned about 0.25% of Axon Enterprise worth $160,235,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of AXON. TCI Wealth Advisors Inc. bought a new stake in shares of Axon Enterprise in the 2nd quarter worth $214,000. Duncker Streett & Co. Inc. increased its stake in shares of Axon Enterprise by 3.2% in the 2nd quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company’s stock worth $12,006,000 after purchasing an additional 448 shares in the last quarter. EFG Asset Management North America Corp. lifted its position in shares of Axon Enterprise by 17.8% during the 2nd quarter. EFG Asset Management North America Corp. now owns 12,701 shares of the biotechnology company’s stock valued at $10,511,000 after buying an additional 1,918 shares in the last quarter. New York Life Investment Management LLC increased its stake in shares of Axon Enterprise by 3.2% in the second quarter. New York Life Investment Management LLC now owns 11,044 shares of the biotechnology company’s stock worth $9,144,000 after purchasing an additional 341 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new position in shares of Axon Enterprise in the second quarter worth about $284,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $569.51 on Thursday. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The stock’s fifty day moving average price is $709.82 and its 200-day moving average price is $735.72. The firm has a market cap of $44.94 billion, a P/E ratio of 140.62, a P/E/G ratio of 29.49 and a beta of 1.45. Axon Enterprise, Inc has a 12 month low of $469.24 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, November 4th. The biotechnology company reported $1.17 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). The firm had revenue of $710.64 million during the quarter, compared to the consensus estimate of $704.83 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business’s revenue for the quarter was up 30.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.45 earnings per share. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Bank of America upped their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. UBS Group cut their price objective on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Piper Sandler reduced their target price on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. Raymond James Financial reissued an “outperform” rating and set a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Northland Securities set a $800.00 price target on Axon Enterprise in a report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $810.71.

Insider Buying and Selling

In other news, CAO Jennifer H. Mak sold 77 shares of the company’s stock in a transaction on Monday, September 15th. The shares were sold at an average price of $760.00, for a total transaction of $58,520.00. Following the completion of the sale, the chief accounting officer owned 15,003 shares of the company’s stock, valued at $11,402,280. This represents a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Joshua Isner sold 15,919 shares of the firm’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the sale, the president directly owned 238,379 shares of the company’s stock, valued at $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 52,041 shares of company stock valued at $36,794,077 in the last three months. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.